Life Sciences Market Research Report
Report Filter Reset All
Sort By Price
Published Date
Category
Publishers
Report Type
Continents
Regions
Global Arranon Market Insights, Forecast to 2025
Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Arranon market is valued at xx million US$ in 2018 and will reach xx m...
$3,900.00 22 May, 2019 | QYResearch
Global Arranon Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Arranon is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Arranon market is valued at xx million US$ in 2018 and will ...
Global Atriance Market Insights, Forecast to 2025
Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Atriance market is valued at xx million US$ in 2018 and will reach xx...
$3,900.00 22 May, 2019 | QYResearch
Global Atriance Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Atriance is a chemotherapy drug used in T-cell acute lymphoblastic leukemia. The global Atriance market is valued at xx million US$ in 2018 and wil...
Global Inotuzumab Ozogamicin Market Insights, Forecast to 2025
Inotuzumab ozogamicin is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Inot...
$3,900.00 22 May, 2019 | QYResearch
Global Inotuzumab Ozogamicin Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Inotuzumab ozogamicin is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The g...
Global Besponsa Market Insights, Forecast to 2025
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Besponsa market i...
$3,900.00 22 May, 2019 | QYResearch
Global Besponsa Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Besponsa is an antibody-drug conjugate used to treat relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). The global Bespons...
Global Enasidenib Market Insights, Forecast to 2025
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) g...
$3,900.00 22 May, 2019 | QYResearch
Global Enasidenib Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase ...
Global Enasidenib Drugs Market Insights, Forecast to 2025
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) g...
$3,900.00 22 May, 2019 | QYResearch
Global Enasidenib Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase ...
Global Idhifa Market Insights, Forecast to 2025
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene,...
$3,900.00 22 May, 2019 | QYResearch
Global Idhifa Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Idhifa is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (I...
Global Gemtuzumab Ozogamicin Market Insights, Forecast to 2025
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The ...
$3,900.00 22 May, 2019 | QYResearch
Global Gemtuzumab Ozogamicin Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to ...
Global Gemtuzumab Ozogamicin Drugs Market Insights, Forecast to 2025
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The ...
$3,900.00 22 May, 2019 | QYResearch
Global Gemtuzumab Ozogamicin Drugs Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to ...
Global Mylotarg Market Insights, Forecast to 2025
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The global Mylota...
$3,900.00 22 May, 2019 | QYResearch
Global Mylotarg Market Insights, Forecast to 2025
$3,900.00 | 22 May, 2019 | QYResearch
Mylotarg is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The glo...
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
